Bacterial clearance in septic mice is modulated by MCP-1/CCL2 and nitric oxide

Shock

Volumn 39, Issue 1, 2013, Pages 63-69

  Gomes, Rachel N ^a,b   Teixeira Cunha, Mariana G A ^a   Figueiredo, Rodrigo T ^c   Almeida, Patricia E ^a   Alves, Silvio C ^a   Bozza, Patrícia T ^a   Bozza, Fernando A ^b   Bozza, Marcelo T ^c   Zimmerman, Guy A ^d   Castro Faria Neto, Hugo C ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

bacterial infection; Chemokines; nitric oxide; phagocytosis

Indexed keywords

GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PERITONEAL DIALYSIS FLUID; RECOMBINANT CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL INFECTION; BACTERIAL LOAD; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; LEUKOCYTE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM LAVAGE; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PROTEIN EXPRESSION; SEPSIS; SIGNAL TRANSDUCTION;

ANIMALS; ASCITIC FLUID; BACTERIAL INFECTIONS; BUTADIENES; CELLS, CULTURED; CHEMOKINE CCL2; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRILES; PHAGOCYTOSIS; RECOMBINANT PROTEINS; SEPSIS;

EID: 84871975602     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31827802b5     Document Type: Article

References (35)

1. Angus DC, Wax RS: Epidemiology of sepsis: An update. Crit Care Med 29:S109YS116, 2001.
2. Marshall JC: Such stuff as dreams are made on: Nediator-directed therapy in sepsis. Nat Rev Drug Discov 2:391-405, 2003.
3. Cohen J: The immunopathogenesis of sepsis. Nature 420:885-891, 2002.
4. Nathan C: Points of control in inflammation. Nature 420:846-852, 2002.
5. Rot A, von Andrian UH: Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891-928, 2004.
6. Gerard C, Rollins BJ: Chemokines and disease. Nat Immunol 2:108-115, 2001.
7. Nakano Y, Kasahara T, Mukaida N, Ko YC, Nakano M, Matsushima K: Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor. Infect Immun 62:377-383, 1994.
8. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, Kunkel SL: Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: Cross-talk between MCP-1 and leukotriene B4. J Immunol 163:6148-6154, 1999.
9. Amano H, Morimoto K, Senba M, Wang H, Ishida Y, Kumatori A, Yoshimine H, Oishi K, Mukaida N, Nagatake T: Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia. J Immunol 172:398-409, 2004.
10. Gomes RN, Bozza FA, Amancio RT, Japiassu AM, Vianna RC, Larangeira AP, Gouvea JM, Bastos MS, Zimmerman GA, Stafforini DM, et al.: Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock 26:41-49, 2006.
11. Gomes RN, Figueiredo RT, Bozza FA, Pacheco P, Amancio RT, Laranjeira AP, Castro-Faria-Neto HC, Bozza PT, Bozza MT: Increased susceptibility to septic and endotoxic shock in monocyte chemoattractant protein 1/cc chemokine ligand 2Ydeficient mice correlates with reduced interleukin 10 and enhanced macrophage migration inhibitory factor production. Shock 26:457-463, 2006.
12. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28:34-39, 1994.
13. Spain DA, Wilson MA, Bar-Natan MF, Garrison RN: Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia. J Trauma 36:720-725, 1994.
14. Moilanen E, Vapaatalo H: Nitric oxide in inflammation and immune response. Ann Med 27:359-367, 1995.
15. Tsai WC, Strieter RM, Zisman DA, Wilkowski JM, Bucknell KA, Chen GH, Standiford TJ: Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect Immun 65:1870-1875, 1997.
16. Biswas SK, Sodhi A, Paul S: Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1. Nitric Oxide 5:566-579, 2001.
17. Bossink AW, Paemen L, Jansen PM, Hack CE, Thijs LG, Van Damme J: Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 86:3841-3847, 1995.
18. Forslund T, Sundqvist T: Nitric oxideYreleasing particles inhibit phagocytosis in human neutrophils. Biochem Biophys Res Commun 233:492-495, 1997.
19. Franchini A, Conte A, Ottaviani E: Nitric oxide: An ancestral immunocyte effector molecule. Adv Neuroimmunol 5:463-478, 1995.
20. Moncada S: The 1991 Ulf von Euler Lecture. The L-arginine: Nitric oxide pathway. Acta Physiol Scand 145:201-227, 1992.
21. Cross AS, Opal SM: A new paradigm for the treatment of sepsis: Is it time to consider combination therapy? Ann Intern Med 138:502-505, 2003.
22. Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, Shofer FS, Goyal M: Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38:1045-1053, 2012.
23. Siddiqui S, Salahuddin N, Raza A, Razzak J: How early do antibiotics have to be to impact mortality in severe sepsis? A prospective, observational study from an emergency department. J Ayub Med Coll Abbottabad 21:106-110, 2009.
24. Charo IF, Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610-621, 2006.
25. Balamayooran G, Batra S, Balamayooran T, Cai S, Jeyaseelan S: Nonocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection. Infect Immun 79:2567-2577, 2011.
26. Jia T, Serbina NV, Brandl K, Zhong MX, Leiner IM, Charo IF, Pamer EG: Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. J Immunol 180:6846-6853, 2008.
27. Hauser B, Radermacher P, Thiemermann C, Matejovic M: Nitric oxide, bacteria, and host defense in sepsis: Who needs what? Shock 22:588-590, 2004.
28. Beck PL, Xavier R, Wong J, Ezedi I, Mashimo H, Mizoguchi A, Mizoguchi E, Bhan AK, Podolsky DK: Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am J Physiol Gastrointest Liver Physiol 286: G137YG147, 2004.
29. Liew FY: Nitric oxide in infectious and autoimmune diseases. Ciba Found Symp 195:234-239; discussion 239-244, 1995.
30. MacMicking J, Xie QW, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350, 1997.
31. Vromen A, Arkovitz MS, Zingarelli B, Salzman AL, Garcia VF, Szabo C: Lowlevel expression and limited role for the inducible isoform of nitric oxide synthase in the vascular hyporeactivity and mortality associated with cecal ligation and puncture in the rat. Shock 6:248-253, 1996.
32. Kilbourn RG, Szabo C, Traber DL: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: Lessons learned from experimental and clinical studies. Shock 7:235-246, 1997.
33. Linares E, Giorgio S, Mortara RA, Santos CX, Yamada AT, Augusto O: Role of peroxynitrite in macrophage microbicidal mechanisms in vivo revealed by protein nitration and hydroxylation. Free Radic Biol Med 30:1234-1242, 2001.
34. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, et al.: Nultiple-center, randomized, placebocontrolled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 32:21-30, 2004.
35. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT: Cytokine profiles as markers of disease severity in sepsis: A multiplex analysis. Crit Care 11:R49, 2007.